Development
abrdn Healthcare Investors
HQH
$16.45
$0.191.17%
| Weiss Ratings | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | abrdn Inc. | |||
| Manager/Tenure (Years) | Jason C. Akus (1) | |||
| Website | http://www.abrdn.com/us | |||
| Fund Information | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | abrdn Healthcare Investors | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Apr 23, 1987 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.90% | |||
| Asset Allocation | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.19% | |||
| Stock | 90.19% | |||
| U.S. Stock | 81.01% | |||
| Non-U.S. Stock | 9.18% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 5.91% | |||
| Convertible | 0.22% | |||
| Other Net | 0.49% | |||
| Price History | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.17% | |||
| 30-Day Total Return | -15.80% | |||
| 60-Day Total Return | -16.20% | |||
| 90-Day Total Return | -11.06% | |||
| Year to Date Total Return | -11.06% | |||
| 1-Year Total Return | -8.12% | |||
| 2-Year Total Return | -3.57% | |||
| 3-Year Total Return | -5.24% | |||
| 5-Year Total Return | 21.66% | |||
| Price | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $15.85 | |||
| 1-Month High Price | $17.07 | |||
| 52-Week Low Price | $15.78 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price | $19.67 | |||
| 52-Week High Price (Date) | Aug 21, 2024 | |||
| NAV | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $17.20 | |||
| 1-Month Low NAV | $17.20 | |||
| 1-Month High NAV | $18.80 | |||
| 52-Week Low NAV | $17.20 | |||
| 52-Week Low NAV (Date) | Apr 01, 2025 | |||
| 52-Week High NAV | $21.30 | |||
| 52-Week High Price (Date) | Aug 21, 2024 | |||
| Beta / Standard Deviation | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 13.69 | |||
| Balance Sheet | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 951.21M | |||
| Operating Ratios | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.18% | |||
| Turnover Ratio | 44.00% | |||
| Performance | HQH-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 11.39% | |||
| Last Bear Market Total Return | -7.82% | |||